Contraception et obésité

Obesity prevalence in industrialized countries has been dramatically increasing for several decades. Obese women are sexually active but they use fewer contraceptive methods and are at high risk of unintended pregnancy. In addition, obesity is an important risk factor for venous thromboembolism events and arterial thrombosis (myocardial infarction and ischemic stroke). All these data are to be considered when choosing a contraceptive method for obese women. The purpose of this paper is to exhaustively review contraceptive methods available in France in 2017 and to evaluate the benefits–risks balance of each of them in obese women.